v3.25.2
Stock-Based Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 20, 2025
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Jan. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock option grants [1]       1,471,000      
Aggregate fair value of RSA granted            
Proceeds for issuance       $ 141 $ 353    
Restricted Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock awards granted       2,686,800      
2018 Long-Term Incentive Equity Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares reserved for issuance       18,342,201      
Shares available for issue       1,001,663     4,018,163
2018 Long-Term Incentive Equity Plan [Member] | Employees [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock options granted 1,321,000            
Weighted average exercise price $ 1.49            
2018 Long-Term Incentive Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Weighted average estimated fair value       $ 0.93 $ 0.80    
2018 Long-Term Incentive Equity Plan [Member] | Restricted Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock awards granted 2,686,800            
Aggregate fair value of RSA granted $ 4,000            
Outside of 2018 Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock option grants       523,300   523,300  
Outside of 2018 Plan [Member] | Share-Based Payment Arrangement, Option [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock option grants       523,300      
Outside of 2018 Plan [Member] | Restricted Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock awards granted       50,000      
Employee Stock Purchase Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares reserved for issuance       2,500,000      
Shares available for issue       1,056,779      
Number of common stock purchased   203,051 511,884        
Proceeds for issuance   $ 141 $ 353        
[1] Stock options granted under the Lucid Diagnostics 2018 Equity Plan and those granted outside such plan generally vest one-third in one year then ratably over the next eight quarters, and have a ten-year contractual term from date-of-grant.